Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2000
12/27/2000CN1278263A 2,3-diaryl-pyrazolo [1,5-B] pyridazines derivatives, their prepn. and use as cyclooxygenase 2 (cox-2) inhibitors
12/27/2000CN1278261A Novel camptothecin derivatives
12/27/2000CN1278256A Ureido and thioureido derivatives of 4-amino-2-(5H)-furanones and 4-amino-2(5H)-thiophenones as antitumor agents
12/27/2000CN1278251A Novel carboxylic acid derivatives which carry amide side chains, prodn. of same, and use as endothelin receptor antagonists
12/27/2000CN1278250A Vitronectin receptor antagonists
12/27/2000CN1278247A Alpha-hydroxy, amino and -fluoro derivatives of beta-sulphenyl hydroxamic acids matrix metalloproteinases inhibitors
12/27/2000CN1278245A Malonic acid based matric metalloproteinase inhibitors
12/27/2000CN1278244A Dipeptide nitriles
12/27/2000CN1278178A Use of macrolies for treating cancer and macular degeneration
12/27/2000CN1278172A Azabenzimidazole-based compounds for modulating serine/threonine protein kinase function
12/27/2000CN1278169A (N,N')-bis (sulfonyl) hydrazines useful as antineoplastic agents
12/27/2000CN1278007A Human interleukin 2 derivatives and human heart sodium medium fusion gene, its protein products and use thereof
12/27/2000CN1277849A Pharmaceuticals for treating and preventing cancer and its prepn. art
12/27/2000CN1277821A Natural and health-care food and its prepn. method
12/27/2000CN1059905C Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
12/27/2000CN1059902C Estrogen excitant/antagonist
12/27/2000CN1059835C Plaster used for anti-cancer and relieving pain
12/27/2000CN1059833C Anticancer medicine and its preparation method
12/27/2000CN1059831C Traditional Chinese medicine preparation for treating leukocythemia
12/27/2000CN1059800C Injection containing ginseng and astragalus root components
12/26/2000USRE37003 Unit dosage form of a 1,3-bis-triazolyl-2-propanol derivative of given formula; side effect reduction
12/26/2000US6166185 Antibodies to human TIE-2 ligands
12/26/2000US6166178 Polypeptide for the treatment of cancer; anticarcinogenic agents
12/26/2000US6166087 Immunosuppresants, antiinflammatory agents, antitumor agents;applying to mucous membranes
12/26/2000US6166075 A 3,4-diphenylbicyclo(4.3.0)nonyl compound
12/26/2000US6166074 Pharmaceutical compositions
12/26/2000US6166053 Antiproliferative agent for treating cancer
12/26/2000US6166048 Pharmaceutical compositions for inhibition of cytokine production and secretion
12/26/2000US6166024 Via formulations adapted for delayed-release oral or rectal administration
12/26/2000US6166005 Heterocyclic metalloprotease inhibitors
12/26/2000US6166003 Heterocyclic compounds for cancer chemoprevention
12/26/2000US6165996 Compounds with chelation affinity selectivity for first transition series elements: use in medical therapy and diagnosis
12/26/2000US6165980 Distamycin derivatives, wherein the distamycin formyl group is substituted by a benzoyl group bearing alkylating group a bis-halo-ethylamino or a n-alkyl-n-haloethyl-amino group, while amidine group is substituted by various nitrogen groups
12/26/2000US6165791 Nucleotide sequences which prevent the transcription of genes associated with an activator of transcription; for the treatment of cell proliferation defects; antiproliferative agents; anticarcinogenic agents
12/26/2000US6165790 Antisense modulation of PI3 kinase p55 gamma expression
12/26/2000US6165788 Antisense modulation of Survivin expression
12/26/2000US6165771 Compounds
12/26/2000US6165767 Protein phosphatase-related molecules
12/26/2000US6165751 HLDAT86 polynucleotides
12/26/2000US6165732 Drug screening by using lipid bilayer that has potassium- or chloride-selective channel formed from polpeptide of bcl-2 family, contacting compound with bilayer, and determining ion-selectivity of channel; indicates agonist or antagonist
12/26/2000US6165476 Fusion proteins with an immunoglobulin hinge region linker
12/26/2000US6165470 Hybrid macromolecules composed of albumin derivatives coupled to derivatives of the cd4 receptor having a normal or a higher affinity for the hiv-1 virus.
12/26/2000US6165464 Monoclonal antibodies directed to the HER2 receptor
12/26/2000US6165462 Sugar kinase
12/26/2000US6165461 Tao protein kinases and methods of use therefor
12/26/2000US6165460 Generation of immune responses to prostate-specific antigen (PSA)
12/26/2000US6165440 Radiation and nanoparticles for enhancement of drug delivery in solid tumors
12/26/2000US6163947 Method of making a hollow-tube brachytherapy device
12/25/2000CA2276219A1 Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction
12/21/2000WO2000077255A1 49 human secreted proteins
12/21/2000WO2000077246A2 A METHOD FOR IDENTIFYING A DRUG CANDIDATE HAVING AN INHIBITORY ACTION ON FVII-TF ACTIVITY, AND FVIIa/TF ACTIVITY INHIBITING COMPOUNDS
12/21/2000WO2000077237A1 49 human secreted proteins
12/21/2000WO2000077221A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production
12/21/2000WO2000077207A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
12/21/2000WO2000077206A2 The myostatin gene promoter and inhibition of activation thereof
12/21/2000WO2000077199A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000WO2000077197A1 47 human secreted proteins
12/21/2000WO2000077191A1 Tumor necrosis factor related receptor, tr6
12/21/2000WO2000077186A2 Bacterial protection against stress
12/21/2000WO2000077184A1 Caspase-8 crystals, models and methods
12/21/2000WO2000077179A2 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000WO2000077173A1 42 human secreted proteins
12/21/2000WO2000077040A2 Human intracellular signaling molecules
12/21/2000WO2000077037A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/21/2000WO2000077023A1 48 human secreted proteins
12/21/2000WO2000077022A1 50 human secreted proteins
12/21/2000WO2000077021A1 48 human secreted proteins
12/21/2000WO2000077014A1 Aryl phosphates
12/21/2000WO2000076988A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids
12/21/2000WO2000076980A1 Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
12/21/2000WO2000076971A2 Serine protease inhibitors
12/21/2000WO2000076953A1 Benzene derivatives, preparation method and pharmaceutical compositions containing same
12/21/2000WO2000076556A2 High dose radionuclide complexes for bone marrow suppression
12/21/2000WO2000076553A1 Use of viral vectors and charged molecules for gene therapy
12/21/2000WO2000076551A2 Method for producing an injectable medicament preparation
12/21/2000WO2000076550A2 Carrier-drug conjugate
12/21/2000WO2000076537A2 Use of semi-allogeneic cell line-peptide complexes for the treatment of cancer, aids and other viral diseases
12/21/2000WO2000076531A1 47 human secreted proteins
12/21/2000WO2000076530A1 49 human secreted proteins
12/21/2000WO2000076528A2 Pharmaceutical preparation containing proteins
12/21/2000WO2000076527A2 New molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy
12/21/2000WO2000076525A1 Anticancer emulsions containing anthracycline compounds
12/21/2000WO2000076523A1 Methods for modulating fxr receptor activity
12/21/2000WO2000076519A1 Sulfonamide and sulfamide substituted imidazoquinolines
12/21/2000WO2000076518A1 Urea substituted imidazoquinolines
12/21/2000WO2000076505A1 Amide substituted imidazoquinolines
12/21/2000WO2000076503A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000WO2000076497A1 Cancer therapy
12/21/2000WO2000076496A1 Tumor tissue accumulation enhancers for drugs
12/21/2000WO2000076487A2 Use of paclitaxel and steriod derivatives as aromatase inhibitors for the treatment of cancer
12/21/2000WO2000076457A2 Il-8 receptor antagonists
12/21/2000WO2000076450A2 Recombinant adenoviruses for the sodium/iodide symporter (nis)
12/21/2000WO2000053628A3 Genes encoding human potassium channel proteins
12/21/2000WO2000053581A3 Heterocyclic compounds having antitumor activity
12/21/2000WO2000050033A3 Anti-tumor synergetic composition
12/21/2000WO2000048621A3 Methods and compositions for regulating protein-protein interactions
12/21/2000WO2000047580A3 Phenyl urea and phenyl thiourea derivatives
12/21/2000WO2000046240A3 Polypeptides involved in immune response
12/21/2000WO2000045791A3 Method for controlling liposome size
12/21/2000WO2000045167A3 Non-invasive method for detecting target rna
1 ... 1861 1862 1863 1864 1865 1866 1867 1868 1869 1870 1871 1872 1873 1874 1875 1876 1877 1878 1879 1880 1881 ... 2211